The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-(5-(3-morpholino-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-ylamino)-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one ID: ALA4475481
PubChem CID: 134461434
Max Phase: Phase
Molecular Formula: C27H22F3N7O3
Molecular Weight: 549.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Nc2ccccc2C(c2ccccc2)=N[C@@H]1Nc1nnc(-c2ncc(C(F)(F)F)cc2N2CCOCC2)o1
Standard InChI: InChI=1S/C27H22F3N7O3/c28-27(29,30)17-14-20(37-10-12-39-13-11-37)22(31-15-17)25-35-36-26(40-25)34-23-24(38)32-19-9-5-4-8-18(19)21(33-23)16-6-2-1-3-7-16/h1-9,14-15,23H,10-13H2,(H,32,38)(H,34,36)/t23-/m1/s1
Standard InChI Key: VGGNPZNYTJXPEW-HSZRJFAPSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
-1.8975 2.9463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6408 2.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8243 1.7841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3100 1.1391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4850 1.1391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9706 1.7841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1542 2.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6127 1.5409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2175 2.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0339 2.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2456 3.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6679 0.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4906 0.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8486 -0.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3839 -1.0908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5612 -1.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2032 -0.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1823 1.5409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4225 2.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2389 2.9064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5494 3.1496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2441 2.0281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5684 2.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9472 3.3295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8873 4.4056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5086 3.8628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3491 3.0533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9704 2.5105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7512 2.7771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9106 3.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2893 4.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0468 5.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6913 3.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8508 4.6626 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3126 3.3103 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.4721 4.1198 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.1066 4.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4853 4.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6447 5.4912 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4255 5.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 1 1 0
8 9 2 0
9 10 1 0
10 11 2 0
2 11 1 0
3 8 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
12 13 2 0
12 17 1 0
4 12 1 0
18 19 1 0
19 20 2 0
6 18 1 1
7 21 2 0
22 23 1 0
23 24 2 0
19 22 1 0
20 24 1 0
25 26 1 0
26 27 2 0
23 27 1 0
28 29 2 0
29 30 1 0
30 31 2 0
26 31 1 0
27 28 1 0
25 32 1 0
30 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
37 38 1 0
38 39 1 0
39 40 1 0
25 37 1 0
32 40 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 549.51Molecular Weight (Monoisotopic): 549.1736AlogP: 4.21#Rotatable Bonds: 5Polar Surface Area: 117.77Molecular Species: ACIDHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: -3.40CX Basic pKa: 1.92CX LogP: 3.56CX LogD: 2.61Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.38Np Likeness Score: -1.06
References 1. Cockerill GS, Good JAD, Mathews N.. (2019) State of the Art in Respiratory Syncytial Virus Drug Discovery and Development., 62 (7): [PMID:30411898 ] [10.1021/acs.jmedchem.8b01361 ] 2. International Nonproprietary Names for Pharmaceutical Substances (INN),